Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.

scientific article

Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOCEL.2009.03.004
P698PubMed publication ID19433314
P5875ResearchGate publication ID24418850

P50authorChristopher J JacksonQ57369585
P2093author name stringMeilang Xue
Ross C Smith
Aiqun Xue
P433issue8-9
P921main subjectadenocarcinomaQ356033
pancreatic adenocarcinomaQ18556189
plasminogenQ107129060
P304page(s)1731-1738
P577publication date2009-03-21
P1433published inInternational Journal of Biochemistry & Cell BiologyQ6051320
P1476titleSuppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling
P478volume41

Reverse relations

cites work (P2860)
Q35019176A deficiency of uPAR alters endothelial angiogenic function and cell morphology
Q64266776Bone as a Preferential Site for Metastasis
Q45835023Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
Q38869026Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells.
Q33620112Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
Q40792801HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor.
Q91916317High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
Q39354315Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma
Q91739170Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets
Q38765928In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody
Q36280308IκB Kinase ε expression in pancreatic ductal adenocarcinoma
Q35200102Myxomaviral Anti-Inflammatory Serpin Reduces Myeloid-Derived Suppressor Cells and Human Pancreatic Cancer Cell Growth in Mice
Q36455613New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice
Q50937761Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Q34704836SPRY1 promotes the degradation of uPAR and inhibits uPAR-mediated cell adhesion and proliferation
Q34483897Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma
Q37132675Targeted alpha therapy approach to the management of pancreatic cancer
Q51656478The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2.
Q47126059Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study

Search more.